JP2002529469A5 - - Google Patents

Download PDF

Info

Publication number
JP2002529469A5
JP2002529469A5 JP2000581028A JP2000581028A JP2002529469A5 JP 2002529469 A5 JP2002529469 A5 JP 2002529469A5 JP 2000581028 A JP2000581028 A JP 2000581028A JP 2000581028 A JP2000581028 A JP 2000581028A JP 2002529469 A5 JP2002529469 A5 JP 2002529469A5
Authority
JP
Japan
Prior art keywords
alkyl
ethyl
methyl
compound
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000581028A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002529469A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1999/026984 external-priority patent/WO2000027850A2/en
Publication of JP2002529469A publication Critical patent/JP2002529469A/ja
Publication of JP2002529469A5 publication Critical patent/JP2002529469A5/ja
Pending legal-status Critical Current

Links

JP2000581028A 1998-11-12 1999-11-12 Crfレセプターアンタゴニストおよびそれに関する方法 Pending JP2002529469A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US19095898A 1998-11-12 1998-11-12
US09/190,958 1998-11-12
US40074499A 1999-09-21 1999-09-21
US09/400,744 1999-09-21
PCT/US1999/026984 WO2000027850A2 (en) 1998-11-12 1999-11-12 Crf receptor antagonists and methods relating thereto

Publications (2)

Publication Number Publication Date
JP2002529469A JP2002529469A (ja) 2002-09-10
JP2002529469A5 true JP2002529469A5 (cg-RX-API-DMAC7.html) 2006-11-24

Family

ID=26886600

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000581028A Pending JP2002529469A (ja) 1998-11-12 1999-11-12 Crfレセプターアンタゴニストおよびそれに関する方法

Country Status (19)

Country Link
US (3) US6348466B1 (cg-RX-API-DMAC7.html)
EP (1) EP1129096B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002529469A (cg-RX-API-DMAC7.html)
KR (1) KR20010080402A (cg-RX-API-DMAC7.html)
CN (1) CN1178941C (cg-RX-API-DMAC7.html)
AT (1) ATE240958T1 (cg-RX-API-DMAC7.html)
AU (1) AU755997B2 (cg-RX-API-DMAC7.html)
BR (1) BR9915129A (cg-RX-API-DMAC7.html)
CA (1) CA2349904A1 (cg-RX-API-DMAC7.html)
DE (1) DE69908173T2 (cg-RX-API-DMAC7.html)
DK (1) DK1129096T3 (cg-RX-API-DMAC7.html)
ES (1) ES2196898T3 (cg-RX-API-DMAC7.html)
HK (1) HK1038925B (cg-RX-API-DMAC7.html)
IL (1) IL143105A0 (cg-RX-API-DMAC7.html)
NO (1) NO20012228D0 (cg-RX-API-DMAC7.html)
NZ (1) NZ511267A (cg-RX-API-DMAC7.html)
PT (1) PT1129096E (cg-RX-API-DMAC7.html)
TR (1) TR200102178T2 (cg-RX-API-DMAC7.html)
WO (1) WO2000027850A2 (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030016222A (ko) * 2000-02-14 2003-02-26 니뽄 다바코 산교 가부시키가이샤 수술후 스트레스 예방ㆍ치료제
EP1278751A1 (en) * 2000-05-01 2003-01-29 Bristol-Myers Squibb Pharma Company Tricyclic fused pyridine and pyrimidine derivatives as crf receptor antagonists
ES2207614T3 (es) * 2000-05-18 2004-06-01 Neurocrine Biosciences, Inc. Antagonistas del receptor de crf y metodos relacionados con estos.
US6541469B2 (en) 2000-05-18 2003-04-01 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods relating thereto
CA2427656A1 (en) * 2000-11-03 2002-05-23 Neurocrine Biosciences, Inc. Crf receptor antagonists and methods relating thereto
AU2002226674B2 (en) 2000-12-28 2007-03-22 Ono Pharmaceutical Co., Ltd. Tricyclic and heterocyclic derivative compounds and drugs containing these compounds as the active ingredient
WO2002064592A1 (en) * 2000-12-28 2002-08-22 Neurocrine Biosciences, Inc. Tricyclic crf receptor antagonists
HUP0304035A2 (hu) 2001-04-30 2004-04-28 Glaxo Group Limited Kortikotropin-releasing faktor (CRF) receptor antagonisták, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
US7273871B2 (en) 2001-07-17 2007-09-25 Sb Pharmco Puerto Rico Inc. Phenyl-5,6,6A,7,8,9-hexahydro-4H-1,4,9-triaza-phenalene derivatives as CRF antagonists
GB0117395D0 (en) * 2001-07-17 2001-09-05 Glaxo Group Ltd Chemical compounds
AU2004249629B2 (en) 2003-06-25 2009-07-30 Ono Pharmaceutical Co., Ltd. Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same
US20060024661A1 (en) * 2003-07-30 2006-02-02 The Regents Of The University Of California Modulation of CRF potentiation of NMDA receptor currents via CRF receptor 2
WO2005063749A1 (en) * 2003-12-22 2005-07-14 Sb Pharmco Puerto Rico Inc Crf receptor antagonists and methods relating thereto
EP1766014A4 (en) 2004-06-03 2008-12-10 Athlomics Pty Ltd AGENTS AND METHODS FOR THE DIAGNOSIS OF STRESS
WO2006031322A2 (en) * 2004-08-09 2006-03-23 Research Development Foundation Determination of the 3d-structure of an extracellular domain of a b1 g-protein coupled receptor by nmr analysis
WO2007050087A1 (en) 2004-08-25 2007-05-03 Ardea Biosciences, Inc. N[S(4-aryl-triazol-3-yl)α -mercaptoacetyl]-p-amino benozoic acids AS HIV REVERSE TRANSCRIPTASE INHIBITORS
ME01512B (me) 2004-08-25 2014-04-20 Ardea Biosciences Inc S-triazolil alfa-merkaptoacetanilida kao inhibitori HIV reversne transkriptaze
ATE541848T1 (de) 2005-05-05 2012-02-15 Ardea Biosciences Inc Diaryl-purin, azapurine und deazapurine als nichtnukleoside reverse-transkriptase-inhibitoren zur behandlung von hiv
EP2132211A4 (en) 2006-11-09 2011-12-07 Ardea Biosciences Inc 4-CYANPHENYLAMINO-SUBSTITUTED BICYCLIC AND HETEROCYCLIC COMPOUNDS AS AN HIV HEMMER
BRPI0819847B1 (pt) 2007-11-27 2022-01-11 Ardea Biosciences, Inc Compostos e composições
EP2220091B1 (en) 2007-12-14 2012-07-25 Ardea Biosciences, Inc. Reverse transcriptase inhibitors

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605642A (en) 1984-02-23 1986-08-12 The Salk Institute For Biological Studies CRF antagonists
US5013737A (en) * 1988-02-22 1991-05-07 American Cyanamid Company 2,4,8-Trisubstituted-3H,6H-1,4,5A,8A-tetraazaacenaphtylene-3,5-(4H)-diones and 2,4-8-trisubstituted-4,5-dihydro-5-thioxo-3H,6H-1,4,5A,8A-tetrazaacenaphthylen-3-ones
US4904658A (en) 1988-04-15 1990-02-27 American Cyanamid Company Substituted-6H,8H-pyrimido-[1,2,3-cd]purine-8,10-(9H)-diones and substituted-6H,10H-pyrimido[1,2-cd]purin-10-ones
US5063245A (en) 1990-03-28 1991-11-05 Nova Pharmaceutical Corporation Corticotropin-releasing factor antagonism compounds
FR2692893B1 (fr) 1992-06-24 1994-09-02 Sanofi Elf Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
DK0674624T3 (da) 1992-12-17 1999-09-13 Pfizer Pyrazoler med CRF-antagonistisk aktivitet
TW336932B (en) 1992-12-17 1998-07-21 Pfizer Amino-substituted pyrazoles
KR100190730B1 (ko) 1992-12-17 1999-06-01 디. 제이. 우드, 스피겔 알렌 제이 부신피질 호르몬 유리인자(crf) 길항물질로서 치환된 피라졸
TW370529B (en) 1992-12-17 1999-09-21 Pfizer Pyrazolopyrimidines
BR9307646A (pt) 1992-12-17 1999-05-25 Pfizer Pirrolopirimidinas como antagonistas de crf
JP3398152B2 (ja) 1993-10-12 2003-04-21 ブリストル‐マイヤーズ・スクイブ・ファーマ・カンパニー 1n−アルキル−n−アリールピリミジンアミンおよびその誘導体
TW574214B (en) 1994-06-08 2004-02-01 Pfizer Corticotropin releasing factor antagonists
ES2135062T3 (es) 1994-06-16 1999-10-16 Pfizer Pirazolo y pirrolopiridinas.
JPH10506126A (ja) 1995-05-12 1998-06-16 ニューロゲン コーポレイション 新規なデアザプリン誘導体;crf1特異性リガンドの新規なクラス
FR2735777B1 (fr) 1995-06-21 1997-09-12 Sanofi Sa Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
CA2249598A1 (en) 1996-03-26 1997-10-02 Paul Joseph Gilligan Aryloxy- and arylthio-fused pyridines and pyrimidines and derivatives
US6107300A (en) 1996-03-27 2000-08-22 Dupont Pharmaceuticals Arylamino fused pyrimidines
US6326368B1 (en) 1996-03-27 2001-12-04 Dupont Pharmaceuticals Company Aryloxy- and arylthiosubstituted pyrimidines and triazines and derivatives thereof
ZA973884B (en) * 1996-05-23 1998-11-06 Du Pont Merck Pharma Tetrahydropteridines and pyridylpiperazines for treatment of neurological disorders
AU747708B2 (en) 1996-07-24 2002-05-23 Du Pont Pharmaceuticals Company Azolo triazines and pyrimidines
DK0920429T3 (da) 1996-08-06 2003-05-12 Pfizer Substituerede pyrido- eller pyrimidoholdige, 6,6- eller 6,7-bicykliske derivater
TW477787B (en) 1996-08-27 2002-03-01 Pfizer Pyrido six-membered nitrogen-containing cyclic ring derivatives having corticotropin releasing factor antagonist activity and pharmaceutical composition containing same
PL332040A1 (en) * 1996-08-28 1999-08-16 Pfizer Substitution 6,5-heterobicyclic derivatives
AU4270297A (en) 1996-09-16 1998-04-02 Du Pont Pharmaceuticals Company Pyrazinones and triazinones and their derivatives thereof
FR2754258B1 (fr) 1996-10-08 1998-12-31 Sanofi Sa Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
US5760225A (en) 1996-11-15 1998-06-02 Neurogen Corporation Certain pyrazole derivatives as corticotropin-releasing factor receptor CRF1 specific ligands
US5723608A (en) 1996-12-31 1998-03-03 Neurogen Corporation 3-aryl substituted pyrazolo 4,3-d!pyrimidine derivatives; corticotropin-releasing factor receptor (CRF1) specific ligands

Similar Documents

Publication Publication Date Title
JP2007517035A5 (cg-RX-API-DMAC7.html)
JP2020521741A5 (cg-RX-API-DMAC7.html)
JP2021534124A5 (cg-RX-API-DMAC7.html)
JP6039067B2 (ja) 抗ウイルス剤としてのトリアゾール化合物
WO2004074270A3 (en) Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
JP2011526917A5 (cg-RX-API-DMAC7.html)
JP2007502293A5 (cg-RX-API-DMAC7.html)
JP2003520856A5 (cg-RX-API-DMAC7.html)
RU2005106846A (ru) Производные бензотиазола, характеризующиеся агонистической активностью к бета-2-адренорецепторам
JP2011507849A5 (cg-RX-API-DMAC7.html)
JP2007517044A5 (cg-RX-API-DMAC7.html)
RU2009132512A (ru) Аналоги 2-5а и способы их применения
RU2005119633A (ru) Антивирусные нуклеозидные производные
RU2016122908A (ru) Соединения дигидропиримидина и их применение в фармацевтических препаратах
JP2006511484A5 (cg-RX-API-DMAC7.html)
CA2584524A1 (en) Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cgmp phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
JPWO2003030937A1 (ja) ミトコンドリアルベンゾジアゼピン受容体アンタゴニストからなるストレス疾患の治療剤
JP2002519325A5 (cg-RX-API-DMAC7.html)
JP2023504541A5 (cg-RX-API-DMAC7.html)
JP2014515385A (ja) 置換アミノイミダゾピリダジン
JP2023538524A5 (cg-RX-API-DMAC7.html)
JP2024543477A5 (cg-RX-API-DMAC7.html)
JP2005527542A5 (cg-RX-API-DMAC7.html)
IL283395B2 (en) Arylmethylureas and substituted heteroarylmethylureas, their analogues and their uses
JP2004525183A5 (cg-RX-API-DMAC7.html)